AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 44 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $6,000 | -25.0% | 10,000 | 0.0% | 0.00% | -50.0% |
| Q3 2019 | $8,000 | +14.3% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $7,000 | -12.5% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $8,000 | -50.0% | 10,000 | 0.0% | 0.00% | -60.0% |
| Q4 2018 | $16,000 | -51.5% | 10,000 | 0.0% | 0.01% | -37.5% |
| Q3 2018 | $33,000 | +43.5% | 10,000 | 0.0% | 0.01% | +33.3% |
| Q2 2018 | $23,000 | -20.7% | 10,000 | 0.0% | 0.01% | -25.0% |
| Q1 2018 | $29,000 | +3.6% | 10,000 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $28,000 | -22.2% | 10,000 | 0.0% | 0.01% | -27.3% |
| Q3 2017 | $36,000 | +63.6% | 10,000 | 0.0% | 0.01% | +57.1% |
| Q2 2017 | $22,000 | +266.7% | 10,000 | 0.0% | 0.01% | +250.0% |
| Q1 2017 | $6,000 | +20.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $5,000 | -44.4% | 10,000 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $9,000 | -10.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $10,000 | +11.1% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $9,000 | -30.8% | 10,000 | 0.0% | 0.00% | -20.0% |
| Q4 2015 | $13,000 | +8.3% | 10,000 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $12,000 | -33.3% | 10,000 | 0.0% | 0.01% | -16.7% |
| Q2 2015 | $18,000 | +28.6% | 10,000 | 0.0% | 0.01% | +20.0% |
| Q1 2015 | $14,000 | +75.0% | 10,000 | 0.0% | 0.01% | +66.7% |
| Q4 2014 | $8,000 | -27.3% | 10,000 | 0.0% | 0.00% | -25.0% |
| Q3 2014 | $11,000 | -38.9% | 10,000 | 0.0% | 0.00% | -42.9% |
| Q2 2014 | $18,000 | +20.0% | 10,000 | 0.0% | 0.01% | +16.7% |
| Q1 2014 | $15,000 | -16.7% | 10,000 | 0.0% | 0.01% | -25.0% |
| Q4 2013 | $18,000 | -18.2% | 10,000 | -6.5% | 0.01% | -38.5% |
| Q3 2013 | $22,000 | -18.5% | 10,700 | 0.0% | 0.01% | -27.8% |
| Q2 2013 | $27,000 | – | 10,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greylock XI GP Limited Partnership | 584,004 | $1,068,000 | 100.00% |
| GREAT POINT PARTNERS LLC | 2,325,000 | $4,255,000 | 1.89% |
| Sarissa Capital Management LP | 2,570,759 | $4,704,000 | 1.60% |
| Deer VI & Co. LLC | 675,242 | $1,236,000 | 0.68% |
| Palo Alto Investors LP | 1,200,800 | $2,197,000 | 0.16% |
| Baupost Group | 3,829,350 | $7,008,000 | 0.11% |
| Gruss Capital Management LP | 533,253 | $976,000 | 0.05% |
| Granahan Investment Management | 676,451 | $1,238,000 | 0.04% |
| Fore Research & Management, LP | 674,200 | $1,233,000 | 0.04% |
| TFS CAPITAL LLC | 210,369 | $385,000 | 0.03% |